Thioacetazone: Difference between revisions
m Protected "Thioacetazone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 19: | Line 19: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Thioacetazone'''([[International Nonproprietary Name|INN]] and [[British Approved Name|BAN]]) is also called '''thiocetazone''', '''thiacetazone''', '''thiosemicarbazone''', '''benzothiozane''' or '''amithiozone'''([[United States Adopted Name|USAN]]); abbreviated '''T.''' | '''Thioacetazone'''([[International Nonproprietary Name|INN]] and [[British Approved Name|BAN]]) is also called '''thiocetazone''', '''thiacetazone''', '''thiosemicarbazone''', '''benzothiozane''' or '''amithiozone'''([[United States Adopted Name|USAN]]); abbreviated '''T.''' | ||
| Line 51: | Line 51: | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 16:51, 20 August 2012
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H12N4OS |
| Molar mass | 236.3 |
|
WikiDoc Resources for Thioacetazone |
|
Articles |
|---|
|
Most recent articles on Thioacetazone Most cited articles on Thioacetazone |
|
Media |
|
Powerpoint slides on Thioacetazone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Thioacetazone at Clinical Trials.gov Trial results on Thioacetazone Clinical Trials on Thioacetazone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Thioacetazone NICE Guidance on Thioacetazone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Thioacetazone Discussion groups on Thioacetazone Patient Handouts on Thioacetazone Directions to Hospitals Treating Thioacetazone Risk calculators and risk factors for Thioacetazone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Thioacetazone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Thioacetazone(INN and BAN) is also called thiocetazone, thiacetazone, thiosemicarbazone, benzothiozane or amithiozone(USAN); abbreviated T.
Thioacetazone is used in the treatment of tuberculosis; it has only weak activity against Mycobacterium tuberculosis and is only useful in preventing resistance to more powerful drugs like isoniazid and rifampicin. It is never used on its own to treat tuberculosis; it is used in a similar way to ethambutol. Thioacetazone is the only anti-TB drug that is ineffective when given intermittently.
There is no advantage to using thioacetazone if the regimen used already contains ethambutol, but many countries in sub-Saharan Africa still use thioacetazone because it is extremely cheap. Use of thioacetazone is declining because it can cause severe (sometimes fatal) skin reactions in HIV positive patients.[1][2]
References
- ↑ Rieder HL, Arnadottir T, Trebucq A, Enarson DA (2001). "Tuberculosis treatment: dangerous regimens?". Int J Tuberc Lung Dis. 5 (1): 1&ndash, 3. PMID 11263509.
- ↑ Nunn P, Porter J, Winstanley P (1993). "Thiacetazone—avoid like poison or use with care?". Trans R Soc Trop Med Hyg. 87 (5): 578&ndash, 82. PMID 7505496.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antibiotics
- Tuberculosis